This website uses cookies to enhance the user experience. Some cookies are essential for the use of the site. View our Privacy Policy and Cookie Policy for more information.
Playroom Podz
Playroom Podz
WI 51 : Dr Henry Friedman
WI 51 : Dr Henry Friedman
Wednesday 25th October 2017
Join Dr. Drew and Dr. Bruce with Dr. Henry Friedman as they discuss innovative brain cancer treatments using modified poliovirus on 'Weekly Infusion'.
41 minutes
Informative
Empowering
Engaging
Thought-provoking
Authentic
About this podcast
Author:
Playroom Podz
Overview:
This multi-part written series of articles is now available in podcast form. Dr. Drew reads “A History of Opium,” which includes additional commentary from recognized experts (available only in this ...(view more)
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
73 (View all)
Do you want to link to this podcast?
Get the buttons here!Breakthroughs in Brain Cancer: Dr. Henry Friedman's Innovative Treatments
Because the modified poliovirus binds to a receptor Cd155, which is on all solid tumors except Burkitt's lymphoma...you just have to treat enough of a lesion to get the systemic response going and you've fired up the immune system in an extraordinarily efficient way.
Imagine battling one of the most aggressive brain cancers with a modified virus. In this episode of 'Weekly Infusion', Dr. Drew and Dr. Bruce Heischober sit down with Dr. Henry Friedman, a leading neuro-oncologist from Duke University, to discuss groundbreaking treatments for brain cancers, particularly glioblastoma multiforme (GBM). Dr. Friedman shares how his team is using a modified poliovirus to attack solid tumors, revealing the science behind this revolutionary approach.
He delves into the potential of combining poliovirus therapy with checkpoint inhibitors and the promising role of dendritic cells in immunotherapy. The conversation also touches on the risks associated with radiation therapy and the need for improved diagnosis and treatment of rare brain tumors. Plus, Dr. Friedman highlights the critical importance of training the next generation of medical professionals. This episode, sponsored by Hydralyte and Alliant CSP, is a must-listen for anyone interested in cutting-edge cancer treatments and medical advancements.